Hope R. Lapointe

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Nondisclosure of use of antiretroviral medications in Canadian blood donors.

Nondisclosure of use of antiretroviral medications in Canadian blood donors.

Journal: Transfusion

Published: June 26, 2025

T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy.

T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy.

Journal: Viruses

Published: March 20, 2024

Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study.

Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study.

Journal: Vaccines

Published: March 06, 2024

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.

Journal: AIDS (London, England)

Published: January 15, 2024

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.

Journal: medRxiv : the preprint server for health sciences

Published: October 24, 2023

Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada.

Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada.

Journal: AIDS (London, England)

Published: August 03, 2023

Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults.

Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults.

Journal: Pathogens & immunity

Published: July 25, 2023

SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy.

SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy.

Journal: AIDS (London, England)

Published: February 15, 2023

Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy.

Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy.

Journal: AIDS (London, England)

Published: December 22, 2022

COVID-19 vaccine immunogenicity in people with HIV.

COVID-19 vaccine immunogenicity in people with HIV.

Journal: AIDS (London, England)

Published: December 08, 2022

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine.

Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine.

Journal: Open forum infectious diseases

Published: October 03, 2022

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells.

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells.

Journal: Nature communications

Published: June 06, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026